First patient treated with Leqembi® (lecanemab) in Sweden

RegulatoryLeqembiPositive

AI Analysis

Summary

BioArctic announced that Leqembi (lecanemab) is now available at a private clinic in Sweden with the first patient beginning treatment, marking the drug's initial use in the Swedish market.

Outcome Details

First patient treated with Leqembi in Sweden at a private clinic

Importance:4/10

Sentiment:

0.60

commercializationSwedenLeqembipatient treatmentmarket access

Related Companies

$BIOA-B.ST

Read the original article

Published by PR Newswire Biotech on September 22, 2026 2:39 PM

Read Original